Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2.77M
-
Shares change
-
+436K
-
Total reported value, excl. options
-
$5.78M
-
Value change
-
+$912K
-
Number of buys
-
18
-
Number of sells
-
-8
-
Price
-
$2.09
Significant Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2025
35 filings reported holding IMMX - Immix Biopharma, Inc. - Common Stock as of Q3 2025.
Immix Biopharma, Inc. - Common Stock (IMMX) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.77M shares
.
Largest 10 shareholders include Bleichroeder LP (850K shares), VANGUARD GROUP INC (730K shares), GEODE CAPITAL MANAGEMENT, LLC (187K shares), MORGAN STANLEY (121K shares), STATE STREET CORP (99K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (90.9K shares), CITADEL ADVISORS LLC (89.8K shares), NORTHERN TRUST CORP (89.3K shares), UNITED CAPITAL FINANCIAL ADVISORS, LLC (70.7K shares), and Imprint Wealth LLC (67.4K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.